Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.76 USD | +0.61% | +4.35% | -29.36% |
Apr. 20 | Immunovant Insider Sold Shares Worth $990,269, According to a Recent SEC Filing | MT |
Apr. 20 | Immunovant Insider Sold Shares Worth $293,923, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 14.41M | Capitalization | 4.32B |
---|---|---|---|---|---|
Net income 2024 * | -250M | Net income 2025 * | -276M | EV / Sales 2024 * | - |
Net cash position 2024 * | 653M | Net cash position 2025 * | 532M | EV / Sales 2025 * | 263 x |
P/E ratio 2024 * |
-16.7
x | P/E ratio 2025 * |
-16.3
x | Employees | 164 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 42.87% |
Latest transcript on Immunovant, Inc.
1 day | +0.61% | ||
1 week | +4.35% | ||
Current month | +8.45% | ||
1 month | -2.49% | ||
3 months | -15.62% | ||
6 months | -10.87% | ||
Current year | -29.36% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Salzmann
CEO | Chief Executive Officer | 56 | 19-05-31 |
Eva Barnett
DFI | Director of Finance/CFO | 44 | 21-10-03 |
Sheetal Patel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
George Migausky
BRD | Director/Board Member | 69 | 19-12-17 |
Andrew Fromkin
BRD | Director/Board Member | 58 | 19-12-17 |
Douglas Hughes
BRD | Director/Board Member | 62 | 19-12-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.09% | 0 M€ | 0.00% | - | |
0.04% | 2 M€ | -.--% | ||
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 29.76 | +0.61% | 804,371 |
24-05-07 | 29.58 | -0.30% | 588,646 |
24-05-06 | 29.67 | +2.81% | 681,356 |
24-05-03 | 28.86 | +0.28% | 701,478 |
24-05-02 | 28.78 | +0.91% | 798,719 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.36% | 4.3B | |
+22.56% | 46.4B | |
-1.51% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+10.13% | 26.01B | |
-20.44% | 19.52B | |
+26.45% | 12.43B | |
-0.14% | 12.18B | |
-0.47% | 12.13B |
- Stock Market
- Equities
- IMVT Stock